Exyte closes 2021 with Record Order Intake 

• Order intake FY 2021 of over €8 billion, more than doubling YOY
• Semiconductor and battery boom are main drivers for increased order intake
• Outlook continues to be very positive 

Stuttgart, 27. January 2022. Exyte, a global leader in the design, engineering, and delivery of facilities for high-tech industries, closed its financial year 2021 with a record order intake of over €8 billion, an increase of more than 100% year-over-year.

With the continued focus on clients in markets with secular growth, from the semiconductor industry and life sciences to data centers, Exyte’s growth is sky-rocketing, continuously reaching new record levels. Exyte had already achieved a record order intake in the first nine months of 2021, amounting to €5.1 billion (9M/2020:
€3.2 billion), and continued with a significant order increase for the fourth quarter of 2021, thus exceeding expectations.

Dr. Wolfgang Büchele, CEO of Exyte, states: “Our strategic focus is driving our business at Exyte. We have been awarded projects for facilities which manufacture semiconductors, batteries, and biopharmaceutical products, products that are continuously high in demand. Supporting our business and enabling further success are internal projects which are harmonizing and optimizing our processes. As a rapidly growing company, we are also looking to fill around 1,500 positions worldwide this year and are offering attractive job opportunities on the world’s largest and most sophisticated projects.”

The ongoing semiconductor and battery boom as well as the need for biopharmaceutical facilities and data centers will continue to accelerate Exyte’s growth. “We entered 2022 with an order backlog of well over €6 billion, an increase of more than 100% when compared to the previous year, putting Exyte in a very comfortable position at the start of a new year,” says Peter Schönhofer, CFO at Exyte. “Newly awarded projects in our focus industries and a very well filled opportunity pipeline will secure another record-breaking year for Exyte in 2022.”